Walleye Capital LLC Global Blood Therapeutics, Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $2.03 Million - $4.28 Million	-62,712 Reduced 58.72%	44,084 $3 Million
Q2 2022 Aug 08, 2022	BUY	$22.3 - $37.39 $896,393 - $1.5 Million	40,197 Added 60.36%	106,796 $3.41 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $1.71 Million - $2.37 Million	66,599 New	66,599 $2.31 Million
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $185,432 - $242,147	-4,762 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $179,289 - $303,672	4,762 New	4,762 $206,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.